Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.42 is 100% below its 5-year average of 1403.82, near the low end of its 5-year range (0.00–13939.67).
As of the fiscal period ended Wednesday, December 31, 2025. 67.85% below its 12-month average of 4.40.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2025-12-31): 1.42.
QUICK RATIO (ACID-TEST)
1.42
QUICK RATIO (ACID-TEST) AVG TTM
4.40
QUICK RATIO (ACID-TEST) AVG 3Y
11.66
QUICK RATIO (ACID-TEST) AVG 5Y
1403.82
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-67.85%
CURRENT VS 3Y AVG
-87.86%
CURRENT VS 5Y AVG
-99.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 849 covered companies
CURRENT VS SECTOR MEDIAN
-57.76%
vs the sector median at left
Regencell Bioscience Holdings Limited
Market Cap
$3.75B
Quick Ratio (Acid-Test)
1.42
TTM Avg
4.40
3Y Avg
11.66
5Y Avg
1403.82
Market Cap
$3.55B
Quick Ratio (Acid-Test)
3.75
TTM Avg
5.09
3Y Avg
3.82
5Y Avg
4.05
Market Cap
$3.95B
Quick Ratio (Acid-Test)
1.21
TTM Avg
1.33
3Y Avg
1.21
5Y Avg
1.93
Market Cap
$3.99B
Quick Ratio (Acid-Test)
18.27
TTM Avg
19.28
3Y Avg
19.95
5Y Avg
29.41
Market Cap
$3.48B
Quick Ratio (Acid-Test)
50.82
TTM Avg
11.65
3Y Avg
9.40
5Y Avg
9.07
Market Cap
$3.48B
Quick Ratio (Acid-Test)
21.02
TTM Avg
15.64
3Y Avg
20.34
5Y Avg
22.11
Market Cap
$3.48B
Quick Ratio (Acid-Test)
10.45
TTM Avg
13.16
3Y Avg
14.41
5Y Avg
11.78
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Regencell Bioscience Holdings Limited (RGC) | $3.75B | 1.42 | 4.40 | 11.66 | 1403.82 |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.55B | 3.75 | 5.09 | 3.82 | 4.05 |
| ICU Medical, Inc. (ICUI)vs › | $3.95B | 1.21 | 1.33 | 1.21 | 1.93 |
| Veracyte, Inc. (VCYT)vs › | $3.53B | 8.80 | 6.13 | 5.10 | 7.69 |
| Relay Therapeutics, Inc. (RLAY)vs › | $3.99B | 18.27 | 19.28 | 19.95 | 29.41 |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.48B | 50.82 | 11.65 | 9.40 | 9.07 |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.48B | 21.02 | 15.64 | 20.34 | 22.11 |
| Celcuity Inc. (CELC)vs › | $3.47B | 8.93 | 9.13 | 14.29 | 16.91 |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | 10.45 | 13.16 | 14.41 | 11.78 |
| AbCellera Biologics Inc. (ABCL)vs › | $4.02B | 12.63 | 10.52 | 9.25 | 8.76 |
Quick Ratio
1.42
Excludes inventory
Current Ratio
1.42
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2025-12-31 | 1.42 |
| 2025-06-30 | 7.39 |
| 2024-12-29 | 0.00 |
| 2024-06-30 | 41.92 |
| 2023-12-30 | 0.00 |
| 2023-06-30 | 19.24 |
| 2022-12-30 | 0.00 |
| 2022-06-30 | 28.51 |
| 2021-12-30 | 13939.67 |
| 2021-06-30 | 0.02 |
| 2020-12-30 | 0.09 |
| 2020-06-30 | 0.12 |
| 2019-12-30 | 0.00 |
